Status:
COMPLETED
Regional Observation of the Metabolic Syndrome
Lead Sponsor:
AstraZeneca
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
40-74 years
Brief Summary
The aim of the study, is to assess the prevalence of metabolic syndrome in Italy on a regional basis, defined according to National Cholesterol Education Program/Adult Treatment Panel III (NCEP/ATPIII...
Eligibility Criteria
Inclusion
- Signed informed consent
- Laboratory analysis (lipidic profile and glycemia) performed in the last year
Exclusion
- Subjects with serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's successful participation in the study
- Pregnancy or breast feeding
- Patients enrolled in clinical studies which the aim is to evaluate the efficacy and/or tolerability of anti-hypertensive and/or lipid lowering drugs
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2010
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT00874952
Start Date
March 1 2009
End Date
February 1 2010
Last Update
February 17 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Torino, Italy